La N-glycosylation du VIH : du modèle expérimental à l'application thérapeutique.
MetadataAfficher la notice complète
Human. immunodeficiency virus type-1 (HIV) envelope precursor glycoprotein (gp160) is cleaved into gp120 and gp41 ; gp120 and gp41 are responsible for HIV tropism for CD4+ cells and for viral and cell membrane fusion leading to virus entry into cells, respectively. The functional role of gp160 N-linked glycans (CHO), which represent 50 % of its MW, was studied. During the biosynthesis, it was shown that CHO clusters of gp160 induce the bioactive folding of both gp41 and gp120 : the interaction between abnormally glycosylated gp120 and its CD4 receptor was altered and the accessibility of the V3 loop, a region that plays a key role in membrane fusion was diminished. Such modified properties could account for the impairment of HIV-1 infectivity by glycosylation inhibitors, the prototypes of potential anti-HIV drugs. Similarly, mutation of the gp41 cluster of glycosylation sites inhibited gP160 cleavage and abolished gp41-mediated membrane fusion. In contrast, after biosynthesis, CHO present on mature viral gp120 and gp41 are involved neither in their bioactivity nor in their conformation : the ability of deglycosylated virus to bind and to infect CD4+ cells was reduced by only 10 fold. CHO are then necessary to create but not to maintain the functional conformation Of HIV env products.
Pour citer ce document
Fenouillet, E., La N-glycosylation du VIH : du modèle expérimental à l'application thérapeutique., Med Sci (Paris), 1993, Vol. 9, N° 8-9; p.901-906